Lifshitz Law Firm Investigating PayPal, Enphase Energy, and REGENXBIO

The law firm is looking into potential securities violations and fiduciary duty breaches at several major companies.

Apr. 15, 2026 at 5:40pm

Got story updates? Submit your updates here. ›

A minimalist, photorealistic studio still life featuring a stack of legal documents, a gavel, and a pair of reading glasses, conceptually representing the abstract ideas of corporate governance and shareholder rights.A law firm's investigation into potential corporate wrongdoing at several major companies could lead to shareholder lawsuits and regulatory actions.NYC Today

Lifshitz Law PLLC, a New York-based law firm, has announced investigations into potential securities laws violations and breaches of fiduciary duties at several publicly traded companies, including PayPal Holdings, Inc., Enphase Energy, Inc., and REGENXBIO Inc.

Why it matters

These types of investigations by law firms can often lead to shareholder lawsuits, regulatory actions, and other consequences for the companies involved, impacting their stock prices and public reputations. The findings could also shed light on corporate governance issues and potential wrongdoing at the executive level.

The details

The investigations cover a range of potential issues, from allegations of securities laws violations to claims of breaches of fiduciary duties by company leadership. The law firm is examining the facts and circumstances surrounding these companies to determine if any actionable claims exist that could be pursued on behalf of shareholders.

  • The investigations were announced on April 15, 2026.

The players

Lifshitz Law PLLC

A New York-based law firm that specializes in investigating potential corporate wrongdoing and pursuing shareholder litigation.

PayPal Holdings, Inc.

A major digital payments company traded on the Nasdaq stock exchange.

Enphase Energy, Inc.

A renewable energy technology company that manufactures microinverters for solar panels.

REGENXBIO Inc.

A clinical-stage biotechnology company focused on developing gene therapy treatments.

Got photos? Submit your photos here. ›

The takeaway

These investigations highlight the ongoing scrutiny that public companies face regarding their compliance with securities laws and their fiduciary responsibilities to shareholders. The outcomes could have significant implications for the affected companies and their investors.